Octreotide Dosage Guide
Complete guide to Octreotide dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
50 mcg – 600 mcg
Frequency
3 times per day
Total Daily Dose
150 mcg – 1.8 mg
Route
subcutaneous
Cycle Length
4–24 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Varies by indication.
Acromegaly
50-100mcg three times daily initially, up to 500mcg TID.
LAR (long-acting)
20-30mg IM every 4 weeks.
Administration Method
Subcutaneous injection for immediate-release (between meals). Intramuscular for LAR depot form. Requires monitoring of gallbladder, glucose, and thyroid.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.130 ml
Syringe units: 13.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Octreotide defaults. Adjust values as needed.
Side Effects to Monitor
GI effects (diarrhea, nausea, abdominal pain), gallstones (up to 25% of long-term users), injection site reactions, and blood glucose changes.
Safety Considerations & Risks
High gallstone risk with chronic use. May cause or worsen hyperglycemia or hypoglycemia. Cardiac conduction abnormalities possible.